Study guide
15.2 Sickle Cell Disease
Arab Board Pediatrics Part 1 Written Examination ABHS
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current ABHS Pediatrics Part 1 Exam Facts 1.2 How to Use This Guide & Part 1 Study Strategy
2 Neonatal Care I
2.1 Delivery-Room Management & Neonatal Resuscitation 2.2 Prematurity & Complications of Prematurity 2.3 Neonatal Jaundice & Hyperbilirubinemia
3 Neonatal Care II
3.1 Neonatal Sepsis & Infections 3.2 Neonatal Hypoglycemia & Metabolic Problems 3.3 Common Newborn Problems, Birth Injury & Screening
4 Infectious Diseases
4.1 Fever Without a Source & Sepsis Evaluation 4.2 Viral Exanthems & Common Childhood Infections 4.3 TORCH & Congenital Infections 4.4 Tuberculosis & Chronic/Unusual Pediatric Infections
5 Immunization
5.1 Routine Immunization Schedule & Vaccine Science 5.2 Contraindications, Adverse Events & Special Populations
6 Allergy & Immunology
6.1 Primary Immunodeficiency 6.2 Allergic Disease & Atopy
7 Growth & Development
7.1 Developmental Milestones & Red Flags 7.2 Growth Assessment & Failure to Thrive 7.3 Corrected Age & Preterm Follow-Up 7.4 Developmental & Behavioral Disorders
8 Nutrition
8.1 Breastfeeding & Infant Feeding 8.2 Weaning & Malnutrition 8.3 Micronutrient Deficiencies (Rickets, Iron Deficiency)
9 Pediatric Emergencies I
9.1 Pediatric Basic & Advanced Life Support 9.2 Anaphylaxis & Allergic Emergencies 9.3 Poisoning & Toxicology
10 Pediatric Emergencies II
10.1 Septic Shock & the Critically Ill Child 10.2 Upper Airway Emergencies (Epiglottitis, Foreign Body) 10.3 Non-Accidental Injury & Safeguarding
11 Cardiology
11.1 Cyanotic Congenital Heart Disease 11.2 Acyanotic Congenital Heart Disease & Heart Failure 11.3 Innocent Murmurs & Cardiac Evaluation 11.4 Rheumatic Fever & Acquired Heart Disease
12 Respiratory
12.1 Asthma 12.2 Bronchiolitis & Croup 12.3 Foreign Body Aspiration & Other Airway Disorders
13 Gastroenterology
13.1 Pyloric Stenosis & Vomiting Disorders 13.2 Intussusception & the Surgical Abdomen 13.3 Celiac Disease & Malabsorption 13.4 Hirschsprung Disease & Biliary Atresia
14 Nephrology & Genitourinary
14.1 Nephrotic Syndrome 14.2 Glomerulonephritis & Hematuria 14.3 UTI, Enuresis & Genitourinary Anomalies
15 Hematology & Oncology
15.1 Pediatric Anemias (Iron Deficiency, Thalassemia) 15.2 Sickle Cell Disease 15.3 Leukemia & Childhood Malignancies (incl. Wilms Tumor) 15.4 Bleeding & Platelet Disorders (ITP) & G6PD Deficiency
16 Endocrinology
16.1 Diabetes Mellitus & Diabetic Ketoacidosis 16.2 Thyroid & Adrenal Disorders 16.3 Growth Disorders & Puberty
17 Neurology
17.1 Febrile Seizures 17.2 Epilepsy Syndromes & Status Epilepticus 17.3 Bacterial Meningitis & CNS Infections 17.4 Neuromuscular Disorders & Headache
18 Genetics, Dysmorphology & Metabolism
18.1 Chromosomal Disorders & Dysmorphology 18.2 Inheritance Patterns, Consanguinity & Inborn Errors of Metabolism
19 Fluids, Electrolytes & Pharmacology
19.1 Maintenance Fluids & Dehydration 19.2 Electrolyte Disturbances 19.3 Pediatric Pharmacology & Prescribing/Dosing
20 Dermatology, ENT, Ophthalmology & Musculoskeletal
20.1 Common Pediatric Dermatology 20.2 ENT Disorders 20.3 Ophthalmology (Strabismus, Red Eye, Leukocoria) 20.4 Musculoskeletal & Rheumatologic Disorders
21 Adolescent Medicine & Ethics
21.1 Adolescent Health & Puberty 21.2 Ethics, Consent & Professionalism in Pediatrics
22 Final Review & Exam Strategy
22.1 High-Yield Numbers, Mnemonics & Cross-Topic Review 22.2 Exam-Day Strategy & Time Management
15.2 Sickle Cell Disease
Key Takeaways Explain This Topic AI
Sickle cell disease is caused by a single point mutation (glutamic acid → valine at position 6 of the beta-globin chain), producing HbS, which polymerizes under deoxygenated conditions and deforms red cells into a sickle shape.
Universal newborn screening detects sickle cell disease by hemoglobin electrophoresis or isoelectric focusing (pattern 'FS' = HbF + HbS with no HbA, confirming homozygous disease, versus 'FAS' = trait).
Vaso-occlusive crisis is treated with aggressive IV fluids, scheduled (not PRN) opioid analgesia, and oxygen only if hypoxic -- oxygen does not reverse sickling in a normoxic patient.
Acute chest syndrome is the leading cause of death and requires a new infiltrate on chest X-ray plus a respiratory symptom (fever, cough, chest pain, hypoxia, tachypnea); management includes empiric antibiotics, bronchodilators, incentive spirometry, and exchange or simple transfusion for severe/worsening cases.
Children with sickle cell disease are functionally asplenic by 2-4 years and are at high risk for infection with encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae); penicillin prophylaxis starts at diagnosis (by 2 months of age) and continues until at least age 5, and annual transcranial Doppler (TCD) ultrasound from age 2-16 screens for stroke risk.
Last updated: July 2026
Pathophysiology
Sickle cell disease (SCD) is an autosomal recessive hemoglobinopathy caused by a point mutation in the beta-globin gene that substitutes valine for glutamic acid at the sixth amino acid position, producing hemoglobin S (HbS) . Under conditions of hypoxia, acidosis, dehydration, or fever, deoxygenated HbS polymerizes into rigid rod-like fibers, distorting the red blood cell into the classic sickle shape. Sickled cells are (1) fragile , causing chronic hemolytic anemia, and (2) rigid and adhesive , causing vaso-occlusion in the microvasculature. These two mechanisms -- hemolysis and vaso-occlusion -- explain essentially every clinical manifestation of the disease and are the lens the exam expects you to apply to each vignette.
The most common genotype is homozygous HbSS (sickle cell anemia), but compound heterozygous states -- HbSC disease and HbS-beta-thalassemia -- also cause clinically significant disease, generally milder than HbSS.
Newborn Screening
Universal newborn screening uses hemoglobin electrophoresis or isoelectric focusing on a heel-prick dried blood spot, reported as a hemoglobin pattern:
- Pattern Interpretation
- FA Normal (HbF + HbA)
- FAS Sickle cell trait (carrier) -- HbA present
- FS Sickle cell disease (HbSS) -- no HbA
- FSC HbSC disease
- FS, A-thal HbS-beta-thalassemia
Exam trap: The presence of any HbA on the newborn screen rules out homozygous sickle cell disease -- HbA can only come from a normal beta-globin allele. "FS" with no HbA at all is what confirms disease, not trait. All positive screens require a confirmatory test and referral to a pediatric hematologist, and empiric penicillin prophylaxis is started immediately while confirmation is pending given the high infection risk if the diagnosis is missed.
Vaso-Occlusive Crisis (VOC)
VOC ("pain crisis") is the most common reason for hospital presentation, typically involving the long bones, back, chest, or abdomen. In infants and toddlers, VOC in the small bones of the hands and feet is called dactylitis (hand-foot syndrome) and is often the first clinical manifestation of SCD, typically appearing between 6 months and 2 years (once HbF has declined enough to unmask HbS polymerization).
Management of VOC:
IV or oral hydration at roughly maintenance rate -- avoid over-hydration, which can precipitate acute chest syndrome by increasing pulmonary edema risk
Scheduled (around-the-clock), not PRN, opioid analgesia -- undertreated pain is a common exam trap and a real clinical error; individualized dosing based on the patient's prior effective regimen
Oxygen only if hypoxic (SaO2 <95% or below baseline) -- supplemental oxygen in a normoxic child does not reverse sickling and can suppress erythropoiesis
- Incentive spirometry to reduce atelectasis and the risk of progression to acute chest syndrome
- Identify and treat precipitants: infection, dehydration, cold exposure, acidosis
- Acute Chest Syndrome (ACS)
ACS is the leading cause of death in SCD and the complication the exam tests most aggressively for recognition. Definition: a new pulmonary infiltrate on chest X-ray involving at least one complete lung segment, plus at least one of: fever, cough, chest pain, tachypnea, wheezing, or hypoxia. ACS can be triggered by infection, fat embolism (from bone marrow infarction), or pulmonary vaso-occlusion/infarction, and can also be precipitated by aggressive fluid resuscitation or under-treated VOC with splinting/atelectasis.
Exam trap: A child admitted for VOC who develops fever and a new infiltrate a day or two later has evolved into ACS -- this is a distinct diagnosis requiring escalated management, not just "worse pain crisis."
Management of ACS:
Empiric antibiotics covering both typical and atypical organisms (e.g., a third-generation cephalosporin plus a macrolide)
- Supplemental oxygen to maintain adequate saturation
- Bronchodilators if wheezing/reactive component present
- Incentive spirometry
- Judicious fluid management (avoid over-hydration)
Simple or exchange transfusion for hypoxia, multilobar involvement, or clinical deterioration -- exchange transfusion is preferred in severe or rapidly progressive cases because it lowers the percentage of HbS without raising viscosity as much as simple transfusion
Splenic Sequestration
Acute splenic sequestration is a life-threatening complication in which a large volume of blood pools acutely in the spleen, causing sudden splenic enlargement, a precipitous drop in hemoglobin (often >=2 g/dL below baseline), thrombocytopenia, and hypovolemic shock. It typically occurs in infants and young children (before autosplenectomy is complete, roughly ages 6 months-2 years, sometimes up to age 5-6) and is a recognized cause of sudden death if unrecognized. Management is emergent volume resuscitation and simple blood transfusion; recurrence risk is high, so recurrent sequestration is an indication for elective splenectomy.
Aplastic Crisis
Aplastic crisis (distinct from aplastic anemia) is a transient, severe drop in hemoglobin caused by parvovirus B19 infection, which infects erythroid precursors and temporarily halts red cell production. In children with SCD, who already have shortened red cell survival from chronic hemolysis, even a brief cessation of erythropoiesis produces a precipitous fall in Hb. The hallmark laboratory finding is reticulocytopenia -- unlike a typical hemolytic exacerbation, where reticulocytes are elevated. The child may appear acutely more anemic and fatigued without the severe pain of a classic VOC. Management is supportive: transfusion for symptomatic anemia, monitoring until marrow recovery (typically 1-2 weeks), and counseling that household contacts who are pregnant should be informed because parvovirus B19 can cause fetal hydrops.
Infection Risk and Penicillin Prophylaxis
Repeated splenic infarction leads to functional asplenia by roughly 2-4 years of age , placing children with SCD at high risk for overwhelming infection with encapsulated organisms -- most importantly Streptococcus pneumoniae , and also Haemophilus influenzae type b and Neisseria meningitidis . Any febrile child with SCD requires urgent evaluation, blood culture, and empiric parenteral antibiotics (covering pneumococcus) given the risk of rapidly fatal sepsis.
Prevention:
Oral penicillin V prophylaxis starting by 2 months of age (as soon as the diagnosis is confirmed/suspected), continued at minimum through age 5 , when the highest-risk period for pneumococcal sepsis has passed (many centers continue longer in children with prior invasive pneumococcal disease or after splenectomy)
Full, on-schedule pneumococcal conjugate and polysaccharide vaccination , plus routine immunizations including annual influenza vaccine
Stroke Risk and TCD Screening
Children with HbSS are at markedly elevated risk of overt and silent cerebral infarction from vaso-occlusion in the large intracranial vessels. Transcranial Doppler (TCD) ultrasound measures blood flow velocity in the middle cerebral artery and is used as an annual screening test from age 2 to 16 in children with HbSS/HbS-beta0-thalassemia. A time-averaged mean velocity >=200 cm/s is considered abnormal and identifies children at substantially elevated stroke risk; these children are started on chronic transfusion therapy , which has been shown to dramatically reduce stroke incidence in this population. Velocities in the 170-199 cm/s range are "conditional" and warrant more frequent repeat screening.